Your browser doesn't support javascript.
loading
The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile.
Alafraidi, Mona; Hoang, Lynn; Howitt, Brooke E; Longacre, Teri A; McAlpine, Jessica N; Jamieson, Amy; Singh, Naveena; Gilks, C Blake; Pors, Jennifer.
Afiliação
  • Alafraidi M; Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Hoang L; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Howitt BE; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada.
  • Longacre TA; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • McAlpine JN; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada.
  • Jamieson A; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Singh N; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Gilks CB; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
  • Pors J; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
Histopathology ; 85(4): 660-670, 2024 Oct.
Article em En | MEDLINE | ID: mdl-38890776
ABSTRACT

AIMS:

Decreased oestrogen receptor (ER) expression is a marker of poor prognosis in endometrial carcinomas (EC) of no specific molecular profile (NSMP), but the optimal cut-off to separate high-risk 'low ER' versus low-risk 'high ER' expression has not been defined. Here we characterised the distribution of ER staining in a cohort of ECs. METHODS AND

RESULTS:

Biopsy specimens from 120 cases of NSMP EC were stained for ER and assigned an Allred score. In 66 additional cases ER staining of matched biopsy and hysterectomy were compared. Twelve of 120 tumours had an Allred score of 0-3, including three endometrioid carcinomas (EEA) (one G1, two G3), four clear cell carcinomas (CCC), two mesonephric-like adenocarcinoma (MLA) and one each of gastric-type adenocarcinoma, carcinosarcoma and endometrial carcinoma NOS. Three had Allred scores of 4-5 two MLA and one high-grade carcinoma with yolk sac differentiation. Five had Allred scores of 6 four EEA (one G1, one G2, two G3) and one mixed clear cell and endometrioid carcinoma. The remaining 100 tumours with Allred scores ≥ 7 were all EEA (66 G1, 28 G2, five G3 and one grade unknown). Comparing the biopsy versus hysterectomy ER staining (n = 66), the results were within a single Allred score point, except two cases with strong diffuse expression in the biopsy (Allred 8) and moderate expression in the hysterectomy (Allred 5).

CONCLUSIONS:

Most NSMP ECs (> 80%) show high ER expression (Allred score ≥ 7). All non-endometrioid carcinomas and a few endometrioid carcinomas had lower ER expression (Allred score ≤ 6) or were completely negative.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Estrogênio / Biomarcadores Tumorais / Neoplasias do Endométrio Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Histopathology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Estrogênio / Biomarcadores Tumorais / Neoplasias do Endométrio Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Histopathology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá